Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: OXCARBAZEPINE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for oxcarbazepine filed by Ajanta Pharma USA Inc., approving changes related to the marketed product. This indicates an …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)